Chierrito, T. P. C.; Pedersoli-Mantoani, S.; Roca, C.; Sebastian-Perez, V.; Martinez-Gonzalez, L.; Perez, D. I.; Perez, C.; Canales, A.; Cañada, F. J.; Campillo, N. E.; Carvalho, I.; Martinez, A.
[2018]. Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors. Eur. J. Med. Chem. 2018, 145, 431-444.
Paez, J. A.; Campillo, N. E.
[2018]. Innovative therapeutic potential of cannabinoid receptors as targets in Alzheimer's disease and less well-known diseases. Curr. Med. Chem., 2018, 25, 1-38.
Del Cerro, P.; Alquezar, C.; Bartolome, F.; Gonzalez-Naranjo, P.; Perez, C.; Carro, E.; Paez, J. A.; Campillo, N. E.; Martin-Requero, A.
[2018]. Activation of the cannabinoid type 2 receptor by a novel indazole derivative normalizes the survival pattern of lymphoblasts from patients with late-onset Alzheimer's disease. CNS Drugs 2018, 32, 579-591.
Roca, C.; Requena, C.; Sebastian-Perez, V.; Malhotra, S.; Radoux, C.; Perez, C.; Martinez, A.; Antonio Paez, J.; Blundell, T. L.; Campillo, N. E.
[2018]. . Identification of new allosteric sites and modulators of AChE through computational and experimental tools. J. Enzyme Inhib. Med. Chem. 2018, 33, 1034-1047.
Gandini, A.; Bartolini, M.; Tedesco, D.; Martinez-Gonzalez, L.; Roca, C.; Campillo, N. E.; Zaldivar-Diez, J.; Perez, C.; Zuccheri, G.; Miti, A.; Petralla, A.; Monti, B.; Rossi, M.; Moda, F.; Legname, G.; Martinez, A.; Bolognesi, M. L.
[2018]. Tau-centric multitarget approach for Alzheimer's disease: Development of first-in-class dual Glycogen Synthase Kinase 3beta and tau-aggregation inhibitors. J. Med. Chem. 2018, 61, 7640-7656.
Roca, C.; Martinez-Gonzalez, L.; Daniel-Mozo, M.; Sastre, J.; Infantes, L.; Mansilla, A.; Chaves-Sanjuan, A.; Gonzalez Rubio, J. M.; Gil, C.; Cañada, F. J.; Martinez, A.; Sanchez-Barrena, M. J.; Campillo, N. E.
[2018]. Deciphering the inhibition of the neuronal calcium sensor 1 and the guanine exchange factor Ric8a with a small phenothiazine molecule for the rational generation of therapeutic synapse function regulators. J. Med. Chem. 2018, 61, 5910-5921.
Sánchez-Cruz, A.; Villarejo-Zori, B.; Marchena, M.; Zaldivar-Díez, J.; Palomo, V.; Gil, C.; Lizasoaín, I.; de la Villa, P.; Martínez, A.; de la Rosa, E. J.; Hernández-Sánchez, C.
[2018]. Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa. Mol. Neurodegener. 2018, 13, 19.
Bartolome, F.; de la Cueva, M.; Pascual, C.; Antequera, D.; Fernandez, T.; Gil, C.; Martinez, A.; Carro, E.
[2018]. Amyloid beta-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition. Alzheimer’s Res. Ther. 2018, 10, 24.
Ed. L. Rivas and C. Gil.
[2018]. Drug Discovery for Leishmaniasis. Ed. L. Rivas and C. Gil. Royal Society of Chemistry. 2018, ISBN 978-1-78262-889-7.
Martinez, A.; Gil, C.
[2018]. “Medicinal chemistry strategies to discover new leishmanicidal drugs” en Drug Discovery for Leishmaniasis. Ed. L. Rivas and C. Gil. Royal Society of Chemistry. 2018, 153-178.
Roca, C.; Sebastián-Pérez, V.; Campillo, N. E.
[2018]. "In silico Tools for Target Identification and Drug Molecular Docking in Leishmania" en Drug Discovery for Leishmaniasis. Ed. L. Rivas and C. Gil. Royal Society of Chemistry. 2018, 130-152
Ed. A. Martinez and C. Gil.
[2017]. Comprehensive Medicinal Chemistry III Ed. Vol 1: General Perspectives-The future of Drug Discovery. Ed. A. Martinez and C. Gil. Elsevier. 2017, ISBN 9780128032008
Garcia, A. M.; Brea, J.; González-García, A.; Pérez, C.; Cadavid, M. I.; Loza, M. I.; Martinez, A.; Gil C.
[2017]. Targeting PDE10A GAF domain with small molecules: a way for allosteric modulation with anti-inflammatory effects. Molecules 2017, 22, 1472. doi:10.3390/molecules22091472.
Sebastián-Pérez, V.; Roca, C.; Awale, M.; Reymond, J. L.; Martínez, A.; Gil, C.; Campillo, N. E.
[2017]. The Medicinal and Biological Chemistry (MBC) library: an efficient source on new hits. J. Chem. Inf. Model. 2017, 57, 2143-2151.
Morales-Garcia, J.; Salado, I. G.; Sanz-San Cristobal, M.; Gil, C.; Pérez-Castillo, A.; Martínez, A.; Pérez, D. I.
[2017]. Biological and pharmacological characterization of Benzothiazole based CK-1δ inhibitors in models of Parkinson’s disease. ACS Omega 2017, 2, 5215-5220.
Salado, I. G.; Zaldivar-Diez, J.; Sebastian, V.; Li, L.; Geiger, L.; González, S.; Campillo, N. E.; Morales, A. V.; Perez, D. I.; Martinez, A.
[2017]. Leucine Rich Repeat Kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents. Eur. J. Med. Chem. 2017, 138, 328-342.
Palomo, V.; Perez, D. I.; Roca, C.; Anderson, C.; Rodriguez-Muela, N.; Perez, C.; Morales-Garcia, J. A.; Reyes, J. A.; Campillo, N. E.; Perez-Castillo, A. M.; Rubin, L. L.; Timchenko, L. T.; Gil, C.; Martinez, A.
[2017]. Subtly modulating Glycogen Synthase Kinase 3 beta: allosteric inhibitors development and their potential for the treatment of chronic diseases. J. Med. Chem. 2017, 60, 4983-5001.
Garcia, A. M.; Salado, I. G.; Perez, D. I.; Brea, J.; Morales-García, J. M.; González-García, A.; Cadavid, M. I.; Loza, M. I.; Luque, F. J.; Perez-Castillo, A.; Martinez, A.; Gil, C.
[2017]. New pharmacological tools based on imidazole scaffold proved the utility of Phosphodiesterase 10 (PDE10) inhibitors for Parkinson’s disease treatment. Fut. Med. Chem. 2017, 9, 707-810.
Contreras, A.; Del Rio, D.; Martinez, A.; Gil, C.; Morales, L.; Ruiz-Gayo, M.; Del Olmo, N.
[2017]. Inhibition of hippocampal long-term potentiation by high-fat diets: is it related to an effect of palmitic acid involving glycogen synthase kinase-3?. Neuroreport 2017, 28, 354-359.
Guerra, A.; Gonzalez-Naranjo, P.; Campillo, N. E. Varela, J.; Lavaggi, M. L.; Merlino, A. Cerecetto, H.; González, M.; Gomez-Barrio, A.; Escario, J.A.; Fonseca-Berzal, C.; Yaluf, G.; Paniagua, J.; Páez, J.
[2017]. Novel Imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxides as antiproliferative trypanosoma cruzi drugs: Computational screening from neural network, synthesis and in vivo biological properties. Eur. J. Med. Chem. 2017 136, 223-234
